{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System",
        "Phoenix Inducible Macrolide Resistance (iMLSb) Test in Staphylococcus species"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K082538",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073653",
        "K020321",
        "K060324",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "November 20, 2008",
    "Summary Letter Received Date": "September 2, 2008",
    "Submission Date": "August 29, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Inducible macrolide-lincosamide-streptogramin B resistance"
    ],
    "Specimen Type(s)": [
        "Pure culture of Gram-positive bacteria",
        "Pure culture of Gram-negative bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated antimicrobial susceptibility testing",
        "Redox indicator growth detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "MIC determination"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Test",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System Inducible Macrolide Resistance (iMLSb) Test for detection of resistance in Staphylococcus species",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative aerobic and facultative anaerobic bacteria and Gram-positive bacteria, including detection of inducible macrolide-lincosamide-streptogramin B resistance in Staphylococcus species.",
    "fda_folder": "Microbiology"
}